Wang et al., 2024 - Google Patents
Perfluoropolyether-Based Gut-Liver-on-a-Chip for the Evaluation of First-Pass Metabolism and Oral Bioavailability of DrugsWang et al., 2024
- Document ID
- 12997167660255752671
- Author
- Wang M
- Sasaki Y
- Sakagami R
- Minamikawa T
- Tsuda M
- Ueno R
- Deguchi S
- Negoro R
- So K
- Higuchi Y
- Yokokawa R
- Takayama K
- Yamashita F
- Publication year
- Publication venue
- ACS Biomaterials Science & Engineering
External Links
Snippet
In the evolving field of drug discovery and development, multiorgans-on-a-chip and microphysiological systems are gaining popularity owing to their ability to emulate in vivo biological environments. Among the various gut-liver-on-a-chip systems for studying oral …
- 239000003814 drug 0 title abstract description 150
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/20—Material Coatings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/16—Microfluidic devices; Capillary tubes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/34—Internal compartments or partitions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/14—Scaffolds; Matrices
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sung et al. | Recent advances in body-on-a-chip systems | |
Ribeiro et al. | Liver microphysiological systems for predicting and evaluating drug effects | |
Khetani et al. | Microengineered liver tissues for drug testing | |
Banaeiyan et al. | Design and fabrication of a scalable liver-lobule-on-a-chip microphysiological platform | |
Zhou et al. | Comprehensive evaluation of organotypic and microphysiological liver models for prediction of drug-induced liver injury | |
Ware et al. | Engineered liver platforms for different phases of drug development | |
Lauschke et al. | Novel 3D culture systems for studies of human liver function and assessments of the hepatotoxicity of drugs and drug candidates | |
Underhill et al. | Advances in engineered human liver platforms for drug metabolism studies | |
Volpe | Advances in cell-based permeability assays to screen drugs for intestinal absorption | |
Shen et al. | Organotypic and microphysiological models of liver, gut, and kidney for studies of drug metabolism, pharmacokinetics, and toxicity | |
Imparato et al. | Organ on chip technology to model cancer growth and metastasis | |
Lin et al. | Advances in engineered liver models for investigating drug‐induced liver injury | |
Dash et al. | Liver tissue engineering in the evaluation of drug safety | |
Kane et al. | Liver-specific functional studies in a microfluidic array of primary mammalian hepatocytes | |
Rezaei Kolahchi et al. | Microfluidic-based multi-organ platforms for drug discovery | |
Kanabekova et al. | Microfluidic organ-on-a-chip devices for liver disease modeling in vitro | |
Ko et al. | Engineering organ-on-a-chip to accelerate translational research | |
Shinha et al. | A kinetic pump integrated microfluidic plate (Kim-plate) with high usability for cell culture-based multiorgan microphysiological systems | |
Dettinger et al. | Automated microfluidic system for dynamic stimulation and tracking of single cells | |
Shuler | Modeling life | |
Boeri et al. | Advanced organ-on-a-chip devices to investigate liver multi-organ communication: focus on gut, microbiota and brain | |
Sung | Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs | |
Bale et al. | Microfluidic cell culture platforms to capture hepatic physiology and complex cellular interactions | |
Cooksey et al. | Reproducibility and robustness of a real-time microfluidic cell toxicity assay | |
Shroff et al. | Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics |